Evidence map›Paper›PMID 27865545›Full record

ArticleNeuropeptides2017

Anti-CGRP antibodies block CGRP-induced diarrhea in mice.

Eric A Kaiser, Brandon J Rea, Adisa Kuburas, Brian R Kovacevich, Leon F Garcia-Martinez, Ana Recober, Andrew F Russo

Open access · greenAbstract read
In one paragraph

Article in Neuropeptides, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Evidence-based review and frontiers of migraine therapy.Neurogastroenterology and motility · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. CGRP in Animal Models of Migraine.Handbook of experimental pharmacology · 2019
    Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Eric A KaiserDepartments of Molecular Physiology and Biophysics, University of Iowa, Iowa City, IA 52242, United States.
Brandon J ReaDepartments of Molecular Physiology and Biophysics, University of Iowa, Iowa City, IA 52242, United States.
Adisa KuburasDepartments of Molecular Physiology and Biophysics, University of Iowa, Iowa City, IA 52242, United States.
Brian R KovacevichAlder Biopharmaceuticals Inc., Bothell, WA 98011, United States.
Leon F Garcia-MartinezAlder Biopharmaceuticals Inc., Bothell, WA 98011, United States.
Ana RecoberDepartment of Neurology, University of Iowa, Iowa City, IA 52242, United States.
Andrew F RussoDepartments of Molecular Physiology and Biophysics, University of Iowa, Iowa City, IA 52242, United States; Department of Neurology, University of Iowa, Iowa City, IA 52242, United States; Veterans Affairs Medical Center, Iowa City, IA 52246, United States. Electronic address: andrew-russo@uiowa.edu.
University of Iowa · USAlder (United States) · USVeterans Health Administration · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007337 · NIGMS · UNIVERSITY OF IOWA · PI GEYER, PAMELA K., LENTZ, STEVEN R · 1985 to 2020
$15.9M
Perivascular mechanisms of CGRP-induced migraine symptomsR01NS075599 · NINDS · UNIVERSITY OF IOWA · PI RUSSO, ANDREW F · 2011 to 2023
$5.0M
Genetic targeting of CGRP actions in a murine model of migraineF30NS067887 · NINDS · UNIVERSITY OF IOWA · PI KAISER, ERIC ALAN · 2010 to 2011
$53k
NIGMS NIH HHS T32 GM007337NINDS NIH HHS F30 NS067887NINDS NIH HHS R01 NS075599
6 · The paper itself

Abstract

The multifunctional neuropeptide calcitonin gene-related peptide (CGRP) and its receptor are expressed throughout the gastrointestinal tract. Previous studies have shown that CGRP has roles in intestinal motility, water secretion, and inflammation. Furthermore, animal studies have demonstrated CGRP involvement in diarrhea secondary to C. difficile and food allergies. Diarrhea thus provides a convenient bioassay of CGRP activity in the GI system. In this proof of principle study, we report that prophylactic administration of an anti-CGRP antibody is able to block CGRP-induced diarrhea in mice. As a control, the CGRP-receptor antagonist olcegepant also attenuated the diarrhea response to CGRP. This preclinical study indicates that anti-CGRP antibodies may provide a new preventative therapy for gastrointestinal disorders involving CGRP.

Indexed as

AnimalsCalcitonin Gene-Related PeptideDiarrheaDisease Models, AnimalInflammationMice, Inbred C57BLMigraine DisordersReceptors, Calcitonin Gene-Related PeptideCalcitonin Gene-Related PeptideReceptors, Calcitonin Gene-Related PeptideAnti-CGRP antibodyCGRPColitisDiarrheaMouse modelOlcegepant

Identifiers

PMID27865545
PMCPMC5429995
OpenAlexW2554491521

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.